In this issue:
DOACs for stroke prevention in AF
FVIII gene transfer for severe haemophilia A
Letermovir for CMV prophylaxis in HCT recipients
Optimising EAT for febrile neutropenia in haematological malignancies
Variations in whole blood donation frequency
Reducing body iron in HFE-related haemochromatosis with moderate iron overload
Dose and ruxolitinib efficacy in Japanese patients with myelofibrosis
Momelotinib vs. ruxolitinib in JAK inhibitor-naïve myelofibrosis
Marizomib, pomalidomide and low-dose dexamethasone for relapsed/refractory myeloma
Please login below to download this issue (PDF)